Handling of iron oxide and silver nanoparticles by astrocytes

Neurochemical Research

Volumn 38, Issue 2, 2013, Pages 227-239

  Hohnholt, Michaela C ^a   Geppert, Mark ^a   Luther, Eva M ^a   Petters, Charlotte ^a   Bulcke, Felix ^a   Dringen, Ralf ^a  

^a UNIVERSITY OF BREMEN   (Germany)

Author keywords

Endocytosis; Ferritin; Metal metabolism; Metallothioneins; ROS; Uptake

Indexed keywords

CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; FERRITIN; FULLERENE DERIVATIVE; IRON OXIDE; MAGNETIC IRON OXIDE NANOPARTICLE; METALLOTHIONEIN; NANOPARTICLE; POLYAMIDOAMINE; POLYGLACTIN; SILICON DIOXIDE; SILVER NANOPARTICLE; SINGLE WALLED NANOTUBE; UNCLASSIFIED DRUG;

ASTROCYTE; CELL CULTURE; CELL DAMAGE; CONCENTRATION (PARAMETERS); CYTOTOXICITY; ENDOCYTOSIS; EXPOSURE; METABOLISM; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNTHESIS; TEMPERATURE DEPENDENCE; UPREGULATION;

ANIMALS; ASTROCYTES; CELLS, CULTURED; FERRIC COMPOUNDS; HUMANS; METAL NANOPARTICLES; SILVER;

EID: 84876410335     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0930-y     Document Type: Review

References (155)

1. Auffan M, Rose J, Bottero JY, Lowry GV, Jolivet JP, Wiesner MR (2009) Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nano 4:634-641
2. Chakraborty M, Jain S, Rani V (2011) Nanotechnology: emerging tool for diagnostics and therapeutics. Appl Biochem Biotechnol 165:1178-1187
3. Ahamed M, AlSalhi MS, Siddiqui MKJ (2010) Silver nanoparticle applications and human health. Clin Chim Acta 411:1841-1848
4. Kokura S, Handa O, Takagi T, Ishikawa T, Naito Y, Yoshikawa T (2010) Silver nanoparticles as a safe preservative for use in cosmetics. Nanomedicine (Lond) 6:570-574
5. Dastjerdi R, Montazer M (2010) A review on the application of inorganic nano-structured materials in the modification of textiles: focus on anti-microbial properties. Colloids Surf B Biointerfaces 79:5-18
6. Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27:76-83
7. Mangematin V, Walsh S (2012) The future of nanotechnologies. Technovation 32:157-160
8. Sharpe M (2006) Small wonders, big future: the development of environmental nanotechnology. J Environ Monit 8:235-239
9. Invernizzi N (2011) Nanotechnology between the lab and the shop floor: what are the effects on labor? J Nanopart Res 13:2249-2268
10. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ (2008) Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20:575-583
11. Tang J, Xiong L, Zhou G, Wang S, Wang J, Liu L, Li J, Yuan F, Lu S, Wan Z, Chou L, Xi T (2010) Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro. J Nanosci Nanotechnol 10:6313-6317
12. 4 nanoparticles in mice. Int J Nanomed 5:861-866
13. van der Zande M, Vandebriel RJ, Van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, Gremmer ER, Mast J, Peters RJ, Hollman PC, Hendriksen PJ, Marvin HJ, Peijnenburg AA, Bouwmeester H (2012) Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6:7427-7442
14. Sharma HS, Hussain S, Schlager J, Ali SF, Sharma A (2010) Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats. Acta Neurochir Suppl 106:359-364
15. Sharma HS, Patnaik R, Sharma A (2010) Diabetes aggravates nanoparticles induced breakdown of the blood-brain barrier permeability, brain edema formation, alterations in cerebral blood flow and neuronal injury. An experimental study using physiological and morphological investigations in the rat. J Nanosci Nanotechnol 10:7931-7945
16. Trickler WJ, Lantz SM, Murdock RC, Schrand AM, Robinson BL, Newport GD, Schlager JJ, Oldenburg SJ, Paule MG, Slikker W Jr, Hussain SM, Ali SF (2010) Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci 118:160-170
17. Kao YY, Cheng TJ, Yang DM, Wang CT, Chiung YM, Liu PS (2012) Demonstration of an olfactory bulb-brain translocation pathway for ZnO nanoparticles in rodent cells in vitro and in vivo. J Mol Neurosci 48:464-471
18. Kwon JT, Hwang SK, Jin H, Kim DS, Minai-Tehrani A, Yoon HJ, Choi M, Yoon TJ, Han DY, Kang YW, Yoon BI, Lee JK, Cho MH (2008) Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J Occup Health 50:1-6
19. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437-445
20. Aschner M (2009) Nanoparticles: transport across the olfactory epithelium and application to the assessment of brain function in health and disease. Prog Brain Res 180:141-152
21. Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP (2010) The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 58:1094-1103
22. Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7-35
23. Jones CE (2012) The emerging role of astrocytes in the metal homeostasis in brain. Global J Inorg Chem 3:4
24. Hirrlinger J, Dringen R (2010) The cytosolic redox state of astrocytes: maintenance, regulation and functional implications for metabolite trafficking. Brain Res Rev 63:177-188
25. Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, Haydon PG, Stout RF Jr, Spray DC, Reichenbach A, Pannicke T, Pekny M, Pekna M, Zorec R, Verkhratsky A (2012) Glial cells in (patho)physiology. J Neurochem 121:4-27
26. Tiffany-Castiglioni E, Hong S, Qian Y (2011) Copper handling by astrocytes: insights into neurodegenerative diseases. Int J Dev Neurosci 29:811-818
27. Scheiber IF, Dringen R (2012) Astrocyte functions in the copper homeostasis of the brain. Neurochem Int (in press)
28. Jeong SY, David S (2003) Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 278:27144-27148
29. Scheiber IF, Schmidt MM, Dringen R (2012) Copper export from cultured astrocytes. Neurochem Int 60:292-300
30. Dringen R, Bishop GM, Koeppe M, Dang TN, Robinson SR (2007) The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem Res 32:1884-1890
31. Tiffany-Castiglioni E, Qian Y (2001) Astroglia as metal depots: molecular mechanisms for metal accumulation, storage and release. Neurotoxicology 22:577-592
32. Focke A, Schwarz S, Foerschler A, Scheibe J, Milosevic J, Zimmer C, Schwarz J (2008) Labeling of human neural precursor cells using ferromagnetic nanoparticles. Magn Reson Med 60:1321-1328
33. Lepore AC, Walczak P, Rao MS, Fischer I, Bulte JW (2006) MR imaging of lineage-restricted neural precursors following transplantation into the adult spinal cord. Exp Neurol 201:49-59
34. Walton RM, Magnitsky SG, Seiler GS, Poptani H, Wolfe JH (2008) Transplantation and magnetic resonance imaging of canine neural progenitor cell grafts in the postnatal dog brain. J Neuropathol Exp Neurol 67:954-962
35. Gramowski A, Flossdorf J, Bhattacharya K, Jonas L, Lantow M, Rahman Q, Schiffmann D, Weiss DG, Dopp E (2010) Nanoparticles induce changes of the electrical activity of neuronal networks on microelectrode array neurochips. Environ Health Perspect 118:1363-1369
36. Rivet CJ, Yuan Y, Borca-Tasciuc DA, Gilbert RJ (2012) Altering iron oxide nanoparticle surface properties induce cortical neuron cytotoxicity. Chem Res Toxicol 25:153-161
37. Pinkernelle J, Calatayud P, Goya GF, Fansa H, Keilhoff G (2012) Magnetic nanoparticles in primary neural cell cultures are mainly taken up by microglia. BMC Neurosci 13:32
38. Fleige G, Nolte C, Synowitz M, Seeberger F, Kettenmann H, Zimmer C (2001) Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 3:489-499
39. Pickard M, Chari D (2010) Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by 'magnetofection': effects of static and oscillating fields. Nanomedicine (Lond) 5:217-232
40. Craparo EF, Bondi ML, Pitarresi G, Cavallaro G (2011) Nanoparticulate systems for drug delivery and targeting to the central nervous system. CNS Neurosci Ther 17:670-677
41. Mahmoudi M, Stroeve P, Milani AS, Arbab AS (2011) Superparamagnetic iron oxide nanoparticles: synthesis, surface engineering, cytotoxicity and biomedical applications. Nova Science Publishers Inc, New York
42. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064-2110
43. Sperling RA, Parak WJ (2010) Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Trans A Math Phys Eng Sci 368:1333-1383
44. Suresh AK, Pelletier DA, Wang W, Morrell-Falvey JL, Gu B, Doktycz MJ (2012) Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types. Langmuir 28:2727-2735
45. Verma A, Stellacci F (2010) Effect of surface properties on nanoparticle-cell interactions. Small 6:12-21
46. 2. Review of in vivo data. Environ Pollut 159:677-684
47. Som C, Wick P, Krug H, Nowack B (2011) Environmental and health effects of nanomaterials in nanotextiles and façade coatings. Environ Int 37:1131-1142
48. Teow Y, Asharani PV, Hande MP, Valiyaveettil S (2011) Health impact and safety of engineered nanomaterials. Chem Commun (Camb) 47:7025-7038
49. Bystrzejewska-Piotrowska G, Golimowski J, Urban PL (2009) Nanoparticles: their potential toxicity, waste and environmental management. Waste Manag 29:2587-2595
50. Suh WH, Suslick KS, Stucky GD, Suh YH (2009) Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol 87:133-170
51. Nohynek GJ, Lademann J, Ribaud C, Roberts MS (2007) Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol 37:251-277
52. Lai CY, Trewyn BG, Jeftinija DM, Jeftinija K, Xu S, Jeftinija S, Lin VS (2003) A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 125:4451-4459
53. Fisichella M, Dabboue H, Bhattacharyya S, Saboungi ML, Salvetat JP, Hevor T, Guerin M (2009) Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicol In Vitro 23:697-703
54. Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VS (2004) A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J Am Chem Soc 126:13216-13217
55. Akhtar MJ, Ahamed M, Kumar MM, Khan MM, Ahmad J, Alrokayan SA (2012) Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine 7:845-857
56. Kao YY, Cheng TJ, Yang DM, Wang CT, Chiung YM, Liu PS (2012) Demonstration of an olfactory bulb-brain translocation pathway for ZnO nanoparticles in rodent cells in vitro and in vivo. J Mol Neurosci 48:464-471
57. 2 nanoparticles. Biomaterials 31:8043-8050
58. Ku S, Yan F, Wang Y, Sun Y, Yang N, Ye L (2010) The blood-brain barrier penetration and distribution of PEGylated fluorescein-doped magnetic silica nanoparticles in rat brain. Biochem Biophys Res Commun 394:871-876
59. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995-4021
60. Lu AH, Salabas EL, Schuth F (2007) Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl 46:1222-1244
61. Fauconnier N, Pons JN, Roger J, Bee A (1997) Thiolation of maghemite nanoparticles by dimercaptosuccinic acid. J Colloid Interface Sci 194:427-433
62. Valois CRA, Braz JM, Nunes ES, Vinolo MAR, Lima ECD, Curi R, Kuebler WM, Azevedo RB (2010) The effect of DMSA-functionalized magnetic nanoparticles on transendothelial migration of monocytes in the murine lung via a β2 integrin-dependent pathway. Biomaterials 31:366-374
63. Soenen SJ, De Cuyper M (2010) Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects. Nanomedicine (Lond) 5:1261-1275
64. Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8:543-557
65. Safi M, Courtois J, Seigneuret M, Conjeaud H, Berret JF (2011) The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials 32:9353-9363
66. Chen ZP, Zhang Y, Xu K, Xu RZ, Liu JW, Gu N (2008) Stability of hydrophilic magnetic nanoparticles under biologically relevant conditions. J Nanosci Nanotechnol 8:6260-6265
67. Weinstein JS, Varallyay CG, Dosa E, Gahramanov S, Hamilton B, Rooney WD, Muldoon LL, Neuwelt EA (2010) Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 30:15-35
68. Winer JL, Kim PE, Law M, Liu CY, Apuzzo ML (2011) Visualizing the future: enhancing neuroimaging with nanotechnology. World Neurosurg 75:626-637
69. Murillo TP, Sandquist C, Jacobs PM, Nesbit G, Manninger S, Neuwelt EA (2005) Imaging brain tumors with ferumoxtran-10, a nanoparticle magnetic resonance contrast agent. Therapy 2:871-882
70. Cromer Berman SM, Walczak P, Bulte JWM (2011) Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 3:343-355
71. Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, Yang VC (2008) Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29:487-496
72. Kempe H, Kates SA, Kempe M (2011) Nanomedicine's promising therapy: magnetic drug targeting. Expert Rev Med Devices 8:291-294
73. Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, von Deimling A, Waldoefner N, Felix R, Jordan A (2007) Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 81:53-60
74. Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V, Jordan A (2011) Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol 103:317-324
75. Thiesen B, Jordan A (2008) Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperthermia 24:467-474
76. Johannsen M, Gneveckow U, Eckelt L, Feussner A, Waldofner N, Scholz R, Deger S, Wust P, Loening SA, Jordan A (2005) Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia 21:637-647
77. Tolaymat TM, El Badawy AM, Genaidy A, Scheckel KG, Luxton TP, Suidan M (2010) An evidence-based environmental perspective of manufactured silver nanoparticle in syntheses and applications: a systematic review and critical appraisal of peer-reviewed scientific papers. Sci Total Environ 408:999-1006
78. Backman U, Jokiniemi JK, Auvinen A, Lehtinen KEJ (2002) The effect of boundary conditions on gas-phase synthesised silver nanoparticles. J Nanopart Res 4:325-335
79. Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH, Kwon IH, Jeong J, Han BS, Shin JH, Sung JH, Song KS, Yu IJ (2007) Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 19:857-871
80. Greulich C, Diendorf J, Simon T, Eggeler G, Epple M, Koeller M (2011) Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater 7:347-354
81. Kang K, Lim DH, Choi IH, Kang T, Lee K, Moon EY, Yang Y, Lee MS, Lim JS (2011) Vascular tube formation and angiogenesis induced by polyvinylpyrrolidone- coated silver nanoparticles. Toxicol Lett 205:227-234
82. Luther EM, Koehler Y, Diendorf J, Epple M, Dringen R (2011) Accumulation of silver nanoparticles by cultured primary brain astrocytes. Nanotechnology 22:375101
83. Kittler S, Greulich C, Gebauer JS, Diendorf J, Treuel L, Ruiz L, Gonzalez-Calbet JM, Vallet-Regi M, Zellner R, Koeller M, Epple M (2010) The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles. J Mater Chem 20:512-518
84. Luther EM, Schmidt MM, Diendorf J, Epple M, Dringen R (2012) Upregulation of metallothioneins after exposure of cultured primary astrocytes to silver nanoparticles. Neurochem Res 37:1639-1648
85. Asharani P, Sethu S, Lim HK, Balaji G, Valiyaveettil S, Hande MP (2012) Differential regulation of intracellular factors mediating cell cycle, DNA repair and inflammation following exposure to silver nanoparticles in human cells. Genome Integr 3:2
86. Asharani PV, Hande MP, Valiyaveettil S (2009) Anti-proliferative activity of silver nanoparticles. BMC Cell Biol 10:65
87. Graf P, Mantion A, Foelske A, Shkilnyy A, Masic A, Thunemann AF, Taubert A (2009) Peptide-coated silver nanoparticles: synthesis, surface chemistry, and pH-triggered, reversible assembly into particle assemblies. Chemistry 15:5831-5844
88. Haase A, Mantion A, Graf P, Plendl J, Thuenemann AF, Meier W, Taubert A, Luch A (2012) A novel type of silver nanoparticles and their advantages in toxicity testing in cell culture systems. Arch Toxicol 86:1089-1098
89. Gopal A, Coventry J, Wan J, Roginski H, Ajlouni S (2010) Alternative disinfection techniques to extend the shelf life of minimally processed iceberg lettuce. Food Microbiology 27:210-219
90. Chen X, Schluesener HJ (2008) Nanosilver: a nanoproduct in medical application. Toxicol Lett 176:1-12
91. Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, Roszek B, Bisschops J, Gosens I, Van De Meent D, Dekkers S, De Jong WH, van Zijverden M, Sips AJAM, Geertsma RE (2009) Nano-silver - a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 3:109-138
92. Yoon KY, Hoon Byeon J, Park JH, Hwang J (2007) Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles. Sci Total Environ 373:572-575
93. Oei JD, Zhao WW, Chu L, Desilva MN, Ghimire A, Rawls HR, Whang K (2012) Antimicrobial acrylic materials with in situ generated silver nanoparticles. J Biomed Mater Res B 100B:409-415
94. Beer C, Foldbjerg R, Hayashi Y, Sutherland DS, Autrup H (2012) Toxicity of silver nanoparticles - nanoparticle or silver ion? Toxicol Lett 208:286-292
95. Liu J, Sonshine DA, Shervani S, Hurt RH (2010) Controlled release of biologically active silver from nanosilver surfaces. ACS Nano 4:6903-6913
96. Kittler S, Greulich C, Köller M, Epple M (2009) Synthesis of PVP-coated silver nanoparticles and their biological activity towards human mesenchymal stem cells. Materialwiss Werkstofftech 40:258-264
97. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V (2010) A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40:328-346
98. Locht LJ, Smidt K, Rungby J, Stoltenberg M, Larsen A (2011) Uptake of silver from metallic silver surfaces induces cell death and a pro-inflammatory response in cultured J774 macrophages. Histol Histopathol 26:689-697
99. Mahmoudi M, Azadmanesh K, Shokrgozar MA, Journeay WS, Laurent S (2011) Effect of nanoparticles on the cell life cycle. Chem Rev 111:3407-3432
100. Mukherjee SG, O'Claonadh N, Casey A, Chambers G (2012) Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines. Toxicol In Vitro 26:238-251
101. Panyala N, Pena-Mendez E, Havel J (2008) Silver or silver nanoparticles: a hazardous threat to the environment and human health? J Appl Biomed 6:117-129
102. Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, Choi J, Hyun JW (2011) Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 201:92-100
103. Yang Z, Liu ZW, Allaker RP, Reip P, Oxford J, Ahmad Z, Ren G (2010) A review of nanoparticle functionality and toxicity on the central nervous system. J R Soc Interface 7(Suppl 4):S411-422
104. Xiu ZM, Zhang QB, Puppala HL, Colvin VL, Alvarez PJ (2012) Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett 12:4271-4275
105. Tang J, Xiong L, Wang S, Wang J, Liu L, Li J, Yuan F, Xi T (2009) Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol 9:4924-4932
106. Yang H (2010) Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. Pharm Res 27:1759-1771
107. Lamkowsky MC, Geppert M, Schmidt MM, Dringen R (2012) Magnetic field-induced acceleration of the accumulation of magnetic iron oxide nanoparticles by cultured brain astrocytes. J Biomed Mater Res A 100A:323-334
108. Geppert M, Hohnholt MC, Nürnberger S, Dringen R (2012) Ferritin up-regulation and transient ROS production in cultured brain astrocytes after loading with iron oxide nanoparticles. Acta Biomater 8:3832-3839
109. Yiu HH, Pickard MR, Olariu CI, Williams SR, Chari DM, Rosseinsky MJ (2012) Fe3O4-PEI-RITC magnetic nanoparticles with imaging and gene transfer capability: development of a tool for neural cell transplantation therapies. Pharm Res 29:1328-1343
110. Pickard MR, Jenkins SI, Koller CJ, Furness DN, Chari DM (2011) Magnetic nanoparticle labeling of astrocytes derived for neural transplantation. Tissue Eng C Methods 17:89-99
111. Geppert M, Hohnholt M, Gaetjen L, Grunwald I, Bäumer M, Dringen R (2009) Accumulation of iron oxide nanoparticles by cultured brain astrocytes. J Biomed Nanotechnol 5:285-293
112. Hohnholt M, Geppert M, Dringen R (2010) Effects of iron chelators, iron salts, and iron oxide nanoparticles on the proliferation and the iron content of oligodendroglial OLN-93 cells. Neurochem Res 35:1259-1268
113. Geppert M, Hohnholt MC, Thiel K, Nurnberger S, Grunwald I, Rezwan K, Dringen R (2011) Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes. Nanotechnology 22:145101
114. Clift MJ, Bhattacharjee S, Brown DM, Stone V (2010) The effects of serum on the toxicity of manufactured nanoparticles. Toxicol Lett 198:358-365
115. Tulpule K, Robinson SR, Bishop GM, Dringen R (2010) Uptake of ferrous iron by cultured rat astrocytes. J Neurosci Res 88:563-571
116. Petri-Fink A, Steitz B, Finka A, Salaklang J, Hofmann H (2008) Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies. Eur J Pharm Biopharm 68:129-137
117. Guarnieri D, Guaccio A, Fusco S, Netti P (2011) Effect of serum proteins on polystyrene nanoparticle uptake and intracellular trafficking in endothelial cells. J Nanopart Res 13:4295-4309
118. Tedja R, Lim M, Amal R, Marquis C (2012) Effects of serum adsorption on cellular uptake profile and consequent impact of titanium dioxide nanoparticles on human lung cell lines. ACS Nano 6:4083-4093
119. Kumari S, Mg S, Mayor S (2010) Endocytosis unplugged: multiple ways to enter the cell. Cell Res 20:256-275
120. Platta HW, Stenmark H (2011) Endocytosis and signaling. Curr Opin Cell Biol 23:393-403
121. Sandvig K, Pust S, Skotland T, van Deurs B (2011) Clathrin-independent endocytosis: mechanisms and function. Curr Opin Cell Biol 23:413-420
122. Ivanov AI (2008) Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol Biol 440:15-33
123. Iversen TG, Skotland T, Sandvig K (2011) Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today 6:176-185
124. Wiogo HT, Lim M, Bulmus V, Yun J, Amal R (2011) Stabilization of magnetic iron oxide nanoparticles in biological media by fetal bovine serum (FBS). Langmuir 27:843-850
125. Jansch M, Stumpf P, Graf C, Rühl E, Müller RH (2012) Adsorption kinetics of plasma proteins on ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. Int J Pharm 428:125-133
126. Voinov MA, Sosa Pagan JO, Morrison E, Smirnova TI, Smirnov AI (2011) Surface-mediated production of hydroxyl radicals as a mechanism of iron oxide nanoparticle biotoxicity. J Am Chem Soc 133:35-41
127. Levy M, Lagarde F, Maraloiu VA, Blanchin MG, Gendron F, Wilhelm C, Gazeau F (2010) Degradability of superparamagnetic nanoparticles in a model of intracellular environment: follow-up of magnetic, structural and chemical properties. Nanotechnology 21:395103
128. Arosio P, Ingrassia R, Cavadini P (2009) Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 1790:589-599
129. Hoepken HH, Korten T, Robinson SR, Dringen R (2004) Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J Neurochem 88:1194-1202
130. van Landeghem FK, Maier-Hauff K, Jordan A, Hoffmann KT, Gneveckow U, Scholz R, Thiesen B, Bruck W, von Deimling A (2009) Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 30:52-57
131. Kurz T, Terman A, Gustafsson B, Brunk U (2008) Lysosomes in iron metabolism, ageing and apoptosis. Histochem Cell Biol 129:389-406
132. Burdo JR, Menzies SL, Simpson IA, Garrick LM, Garrick MD, Dolan KG, Haile DJ, Beard JL, Connor JR (2001) Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res 66:1198-1207
133. Hohnholt MC, Geppert M, Dringen R (2011) Treatment with iron oxide nanoparticles induces ferritin synthesis but not oxidative stress in oligodendroglial cells. Acta Biomater 7:3946-3954
134. Garrick MD, Garrick LM (2009) Cellular iron transport. Biochim Biophys Acta 1790:309-325
135. Wu LJ, Leenders AG, Cooperman S, Meyron-Holtz E, Smith S, Land W, Tsai RY, Berger UV, Sheng ZH, Rouault TA (2004) Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res 1001:108-117
136. Haase A, Rott S, Mantion A, Graf P, Plendl J, Thunemann AF, Meier WP, Taubert A, Luch A, Reiser G (2012) Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses. Toxicol Sci 126:457-468
137. Hidalgo J, Aschner M, Zatta P, Vasak M (2001) Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull 55:133-145
138. Park JS, Jung JS, Jeong YH, Hyun JW, Le TK, Kim DH, Choi EC, Kim HS (2011) Antioxidant mechanism of isoflavone metabolites in hydrogen peroxide-stimulated rat primary astrocytes: critical role of hemeoxygenase-1 and NQO1 expression. J Neurochem 119:909-919
139. Syapin PJ (2008) Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. Br J Pharmacol 155:623-640
140. West AK, Hidalgo J, Eddins D, Levin ED, Aschner M (2008) Metallothionein in the central nervous system: roles in protection, regeneration and cognition. Neurotoxicology 29:489-503
141. Nunes A, Al-Jamal KT, Kostarelos K (2012) Therapeutics, imaging and toxicity of nanomaterials in the central nervous system. J Control Release 161:290-306
142. Kievit FM, Zhang M (2011) Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc Chem Res 44:853-862
143. Kamau SW, Hassa PO, Steitz B, Petri-Fink A, Hofmann H, Hofmann-Amtenbrink M, von Rechenberg B, Hottiger MO (2006) Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field. Nucleic Acids Res 34:e40
144. Au C, Mutkus L, Dobson A, Riffle J, Lalli J, Aschner M (2007) Effects of
145. Ding J, Tao K, Li J, Song S, Sun K (2010) Cell-specific cytotoxicity of dextran-stabilized magnetite nanoparticles. Colloids Surf B Biointerfaces 79:184-190
146. Selva J, Martinez SE, Buceta D, Rodriguez-Vazquez MJ, Blanco MC, Lopez-Quintela MA, Egea G (2010) Silver sub-nanoclusters electrocatalyze ethanol oxidation and provide protection against ethanol toxicity in cultured mammalian cells. J Am Chem Soc 132:6947-6954
147. Bastian S, Busch W, Kuhnel D, Springer A, Meissner T, Holke R, Scholz S, Iwe M, Pompe W, Gelinsky M, Potthoff A, Richter V, Ikonomidou C, Schirmer K (2009) Toxicity of tungsten carbide and cobalt-doped tungsten carbide nanoparticles in mammalian cells in vitro. Environ Health Perspect 117:530-536
148. Belyanskaya L, Weigel S, Hirsch C, Tobler U, Krug HF, Wick P (2009) Effects of carbon nanotubes on primary neurons and glial cells. Neurotoxicology 30:702-711
149. Wang YC, Wu YT, Huang HY, Lin HI, Lo LW, Tzeng SF, Yang CS (2008) Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury. Biomaterials 29:4546-4553
150. Basso AS, Frenkel D, Quintana FJ, Costa-Pinto FA, Petrovic-Stojkovic S, Puckett L, Monsonego A, Bar-Shir A, Engel Y, Gozin M, Weiner HL (2008) Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J Clin Invest 118:1532-1543
151. Tsutsui Y, Tomizawa K, Nagita M, Michiue H, Nishiki T, Ohmori I, Seno M, Matsui H (2007) Development of bionanocapsules targeting brain tumors. J Control Release 122:159-164
152. Kim JB, Choi JS, Nam K, Lee M, Park JS, Lee JK (2006) Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg. J Control Release 114:110-117
153. Pignatello R, Acquaviva R, Campisi A, Raciti G, Musumeci T, Puglisi G (2011) Effects of liposomal encapsulation on the antioxidant activity of lipophilic prodrugs of idebenone. J Liposome Res 21:46-54
154. Montenegro L, Campisi A, Sarpietro MG, Carbone C, Acquaviva R, Raciti G, Puglisi G (2011) In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. Drug Dev Ind Pharm 37:737-746
155. Chang J, Paillard A, Passirani C, Morille M, Benoit JP, Betbeder D, Garcion E (2012) Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells. Pharm Res 29:1495-1505